ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 157 filers reported holding ZAI LAB LTD in Q1 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,190,708 | +8.3% | 35,800 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,099,060 | -10.2% | 35,800 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $1,224,000 | +0.2% | 35,800 | +1.7% | 0.01% | +16.7% |
| Q2 2022 | $1,221,000 | -21.8% | 35,200 | -0.9% | 0.01% | +20.0% |
| Q1 2022 | $1,562,000 | -21.9% | 35,511 | +11.7% | 0.01% | -9.1% |
| Q4 2021 | $1,999,000 | -39.8% | 31,800 | +1.0% | 0.01% | -45.0% |
| Q3 2021 | $3,320,000 | -40.4% | 31,500 | 0.0% | 0.02% | -41.2% |
| Q2 2021 | $5,575,000 | +39.7% | 31,500 | +5.4% | 0.03% | +17.2% |
| Q1 2021 | $3,990,000 | +0.6% | 29,900 | +2.0% | 0.03% | +3.6% |
| Q4 2020 | $3,965,000 | +57.8% | 29,300 | -3.0% | 0.03% | +33.3% |
| Q3 2020 | $2,512,000 | +32.4% | 30,200 | +30.7% | 0.02% | +10.5% |
| Q2 2020 | $1,897,000 | +118.0% | 23,100 | +36.7% | 0.02% | +26.7% |
| Q1 2020 | $870,000 | – | 16,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |